Fontan Udenafil Exercise Longitudinal Assessment Trial

NCT02741115 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Single Ventricle Heart Disease

Interventions

DRUG: Udenafil
DRUG: Placebo

Sponsor

Mezzion Pharma Co. Ltd

Collaborators

[object Object]